EP3247464
USE OF TLR AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.1.2016:
18.9.2019:
16740762.6
:
20.1.2036
:
USE OF TLR AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS
21.1.2016
18.9.2019
:
The Board of Trustees of the Leland Stanford Junior University:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
:
WEISSMAN, Irving L.:
Stanford, California, US
:
FENG, Mingye:
Mountain View, California, US
:
VOLKMER, Jens-Peter:
Menlo Park, California, US
:
201562106050 P:
21.1.2015:
US
:
US2016014334:
21.1.2016
:
A61P 35/00, A61K 39/395, A61K 39/00, A61K 31/33, A61K 35/15, A61K 45/06, A61P 7/00, A61K 31/4745, A61K 31/713, A61K 31/519, C12N 5/0786